Related Experiment Video
Updated: May 23, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Active surveillance for prostate cancer: past, present and future
Eric A Singer1, Aradhana Kaushal, Baris Turkbey
1Urologic Oncology Branch, Center for Cancer Research, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States.
Active surveillance is a viable option for men with low-risk prostate cancer, potentially delaying or avoiding treatment side effects. Further research will refine criteria for this approach, improving quality of life.
Area of Science:
- Urology
- Oncology
- Medical Research
Background:
- Localized prostate cancer management presents challenges for urologic oncologists.
- Prostate-specific antigen screening increases detection of low-risk prostate cancers.
- Radical treatments (surgery, radiation) carry significant side effects like incontinence and erectile dysfunction.
Purpose of the Study:
- To review recent advancements in active surveillance for localized prostate cancer.
- To discuss the role of active surveillance in managing low and intermediate-risk prostate cancer.
- To highlight the potential of active surveillance to improve quality of life.
Main Methods:
- Literature review of recent developments in active surveillance for prostate cancer.
- Analysis of current challenges and benefits of active surveillance strategies.
- Synthesis of findings regarding patient selection, monitoring, and treatment triggers.
Main Results:
- Active surveillance aims to mitigate or postpone adverse events from prostate cancer treatments.
- It allows for future curative intervention if the cancer progresses.
- This approach is suitable for many men with low-risk and some with intermediate-risk prostate cancer.
Conclusions:
- Active surveillance is a practical treatment choice for suitable prostate cancer patients.
- Optimal criteria, monitoring, and treatment triggers for active surveillance require further investigation.
- Advances in imaging, biomarkers, and focal therapy may enhance active surveillance adoption and outcomes.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...